Depomed (DEPO) Misses Q1 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
- Wall St set to fall at open as yields and oil rebound; Fed minutes in focus
- Want to be a stock market bear? BCA says watch potential U.S. tax increases
- SpaceX seeks $40bn in financing for Nvidia chip purchase
- Chip stock could soar nearly 200%, analyst says: "If you don’t buy it, they will"
- Musk rules out TSMC role in Terafab operations; Intel gains
Tweet
Share
E-mailGet Alerts DEPO Hot Sheet
Price: $7.30 --0%
Financial Fact:
Benefit from (Provision for) income taxes: 6.04M
Today's EPS Names:
AEHR, VFS, CMTL, More
Financial Fact:
Benefit from (Provision for) income taxes: 6.04M
Today's EPS Names:
AEHR, VFS, CMTL, More
Join SI Premium – FREE
Depomed (NASDAQ: DEPO) reported Q1 EPS of $0.12, $0.05 worse than the analyst estimate of $0.17. Revenue for the quarter came in at $104.8 million versus the consensus estimate of $107.1 million.
For earnings history and earnings-related data on Depomed (DEPO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Chip stock could soar nearly 200%, analyst says: "If you don’t buy it, they will"
- CoreWeave plans 240 MW India data center with AdaniConneX
- Piper Sandler on Federal Realty Investment Trust (FRT): 'Underwriting Upside Helping Mitigate Higher Rates'
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
